speb/financial-data huggingface dataset:
IR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1144600000.00
IR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 390200000.00
IR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 108500000.00
IR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 108500000.00
IR income_statement (annual, 2025-12-31) — Total Unusual Items: -365400000.00
IR income_statement (quarterly, 2025-12-31) — Total Unusual Items: -33700000.00
IR income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -365400000.00
IR income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -33700000.00
IR balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 40631613.00
IR balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 40631613.00
IR balance_sheet (annual, 2025-12-31) — Treasury Stock: 2519200000.00
IR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2519200000.00
IR balance_sheet (annual, 2025-12-31) — Work In Process: 128700000.00
IR balance_sheet (quarterly, 2025-12-31) — Work In Process: 128700000.00
IR balance_sheet (annual, 2025-12-31) — Working Capital: 2181700000.00
IR balance_sheet (quarterly, 2025-12-31) — Working Capital: 2181700000.00
IR income_statement (quarterly, 2026-03-31) — +Operating Expense: 478200000.00
IR income_statement (quarterly, 2026-03-31) — +Total Revenue: 1847200000.00
IR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 847400000.00
IR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1455200000.00
IR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -711600000.00
IR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 9729400000.00
IR balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -65400000.00
IR income_statement (quarterly, 2026-03-31) — Amortization: 107500000.00
IR cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 107500000.00
IR cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 107500000.00
IR income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 107500000.00
IR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 391400000.00
IR income_statement (quarterly, 2026-03-31) — Basic EPS: 0.49
IR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1248800000.00
IR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -36300000.00
IR cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -36300000.00
IR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 64800000.00
IR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4300000.00
IR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1274400000.00
IR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1274400000.00
IR cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -7800000.00
IR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -83800000.00
IR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -84400000.00
IR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 199700000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -133500000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 16000000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Inventory: -74700000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -23000000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Payable: -133500000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -117500000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Receivables: 59700000.00
IR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -155500000.00
IR cash_flow (quarterly, 2026-03-31) — Changes In Cash: 31500000.00
IR balance_sheet (quarterly, 2026-03-31) — Common Stock: 4300000.00
IR cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -7800000.00
IR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10175100000.00
IR cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -89500000.00
IR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1054800000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 551200000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Assets: 4289800000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 64800000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Debt: 1400000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 66200000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 344700000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 344700000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1926200000.00
IR balance_sheet (quarterly, 2026-03-31) — Current Provisions: 34800000.00
IR cash_flow (quarterly, 2026-03-31) — Depreciation: 29400000.00
IR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 136900000.00
IR income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 107500000.00
IR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 136900000.00
IR income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 107500000.00
IR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 394000000.00
IR income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.49
IR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 192100000.00
IR income_statement (quarterly, 2026-03-31) — EBIT: 293700000.00
IR income_statement (quarterly, 2026-03-31) — EBITDA: 430600000.00
IR income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 0.00
IR cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 0.00
IR cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -5900000.00
IR balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 130200000.00
IR cash_flow (quarterly, 2026-03-31) — End Cash Position: 1274400000.00
IR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -83800000.00
IR balance_sheet (quarterly, 2026-03-31) — Finished Goods: 422400000.00
IR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 163400000.00
IR income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -2200000.00
IR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -189700000.00
IR balance_sheet (quarterly, 2026-03-31) — Goodwill: 8471200000.00
IR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12614000000.00
IR balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1520600000.00
IR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1631600000.00
IR income_statement (quarterly, 2026-03-31) — Gross Profit: 792400000.00
IR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 53700000.00
IR income_statement (quarterly, 2026-03-31) — Interest Expense: 63800000.00
IR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 63800000.00
IR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 34700000.00
IR balance_sheet (quarterly, 2026-03-31) — Interest Payable: 60300000.00
IR balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -102400000.00
IR balance_sheet (quarterly, 2026-03-31) — Inventory: 1236200000.00
IR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 14953900000.00
IR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -84400000.00
IR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4777400000.00
IR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4777400000.00
IR balance_sheet (quarterly, 2026-03-31) — Minority Interest: 64700000.00
IR income_statement (quarterly, 2026-03-31) — Minority Interests: -1700000.00
IR cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -52000000.00
IR cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -89500000.00
IR balance_sheet (quarterly, 2026-03-31) — Net Debt: 3504400000.00
IR cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 2200000.00
IR income_statement (quarterly, 2026-03-31) — Net Income: 192100000.00
IR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 192100000.00
IR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 193800000.00
IR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 192100000.00
IR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 192100000.00
IR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 193800000.00
IR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 193800000.00
IR income_statement (quarterly, 2026-03-31) — Net Interest Income: -63800000.00
IR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -63800000.00
IR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2400000.00
IR balance_sheet (quarterly, 2026-03-31) — Net PPE: 920000000.00
IR cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 3900000.00
IR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2438900000.00
IR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 43200000.00
IR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 716700000.00
IR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 43200000.00
IR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 716700000.00
IR balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 130200000.00
IR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 455100000.00
IR income_statement (quarterly, 2026-03-31) — Normalized Income: 212753500.00
IR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 199700000.00
IR cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2200000.00
IR income_statement (quarterly, 2026-03-31) — Operating Income: 314200000.00
IR income_statement (quarterly, 2026-03-31) — Operating Revenue: 1847200000.00
IR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 391285757.00
IR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 324000000.00
IR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1400000.00
IR balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -189700000.00
IR income_statement (quarterly, 2026-03-31) — Other Income Expense: -20500000.00
IR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4142800000.00
IR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6400000.00
IR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 351200000.00
IR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 427900000.00
IR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 4000000.00
IR balance_sheet (quarterly, 2026-03-31) — Payables: 929300000.00
IR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1480500000.00
IR income_statement (quarterly, 2026-03-31) — Pretax Income: 229900000.00
IR cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 15900000.00
IR cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -52000000.00
IR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 754400000.00
IR balance_sheet (quarterly, 2026-03-31) — Receivables: 1455200000.00
IR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1025400000.00
IR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 136900000.00
IR cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -89500000.00
IR income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 22300000.00
IR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3237400000.00
IR cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 3900000.00
IR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 370700000.00
IR balance_sheet (quarterly, 2026-03-31) — Share Issued: 432842659.00
IR income_statement (quarterly, 2026-03-31) — Special Income Charges: -22300000.00
IR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 15900000.00
IR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10175100000.00
IR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2438900000.00
IR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -3846500.00
IR income_statement (quarterly, 2026-03-31) — Tax Provision: 36100000.00
IR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.16
IR balance_sheet (quarterly, 2026-03-31) — Total Assets: 18218200000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 14952500000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Debt: 4843600000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10239800000.00
IR income_statement (quarterly, 2026-03-31) — Total Expenses: 1533000000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7978400000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13928400000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6052200000.00
IR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 289700000.00
IR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 81900000.00
IR income_statement (quarterly, 2026-03-31) — Total Unusual Items: -24500000.00
IR income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -24500000.00
IR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 41556902.00
IR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2606300000.00
IR balance_sheet (quarterly, 2026-03-31) — Work In Process: 161800000.00
IR balance_sheet (quarterly, 2026-03-31) — Working Capital: 2363600000.00
IR1.AX income_statement (annual, 2022-03-31) — +Operating Expense: 3236744.00
IR1.AX balance_sheet (annual, 2022-03-31) — Accounts Payable: 96043.00
IR1.AX income_statement (annual, 2022-03-31) — Basic Average Shares: 71098356.00
IR1.AX income_statement (annual, 2022-03-31) — Basic EPS: -0.05
IR1.AX cash_flow (annual, 2022-03-31) — Beginning Cash Position: 496418.00
IR1.AX cash_flow (annual, 2022-03-31) — Capital Expenditure: -54248.00
IR1.AX balance_sheet (annual, 2022-03-31) — Capital Stock: 8563117.00
IR1.AX balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 4190042.00
IR1.AX balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 4190042.00
IR1.AX balance_sheet (annual, 2022-03-31) — Cash Financial: 4190042.00
IR1.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 6377295.00
IR1.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -54248.00
IR1.AX cash_flow (annual, 2022-03-31) — Cash Flowsfromusedin Operating Activities Direct: -2629423.00
IR1.AX cash_flow (annual, 2022-03-31) — Changes In Cash: 3693624.00
IR1.AX cash_flow (annual, 2022-03-31) — Classesof Cash Payments: -2519423.00
IR1.AX cash_flow (annual, 2022-03-31) — Classesof Cash Receiptsfrom Operating Activities: -110000.00
IR1.AX balance_sheet (annual, 2022-03-31) — Common Stock: 8563117.00
IR1.AX balance_sheet (annual, 2022-03-31) — Common Stock Equity: 4206528.00
IR1.AX cash_flow (annual, 2022-03-31) — Common Stock Issuance: 7000000.00
IR1.AX cash_flow (annual, 2022-03-31) — Common Stock Payments: -622705.00
IR1.AX balance_sheet (annual, 2022-03-31) — Current Assets: 4355920.00
IR1.AX balance_sheet (annual, 2022-03-31) — Current Liabilities: 199214.00
IR1.AX balance_sheet (annual, 2022-03-31) — Current Provisions: 30000.00
IR1.AX income_statement (annual, 2022-03-31) — Depreciation Amortization Depletion Income Statement: 4426.00
IR1.AX income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 4426.00
IR1.AX income_statement (annual, 2022-03-31) — Depreciation Income Statement: 4426.00
IR1.AX income_statement (annual, 2022-03-31) — Diluted Average Shares: 71098356.00
IR1.AX income_statement (annual, 2022-03-31) — Diluted EPS: -0.05
IR1.AX income_statement (annual, 2022-03-31) — EBIT: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — EBITDA: -3232318.00
IR1.AX cash_flow (annual, 2022-03-31) — End Cash Position: 4190042.00
IR1.AX cash_flow (annual, 2022-03-31) — Financing Cash Flow: 6377295.00
IR1.AX cash_flow (annual, 2022-03-31) — Free Cash Flow: -2683671.00
IR1.AX balance_sheet (annual, 2022-03-31) — Gains Losses Not Affecting Retained Earnings: 680178.00
IR1.AX income_statement (annual, 2022-03-31) — General And Administrative Expense: 1140157.00
IR1.AX balance_sheet (annual, 2022-03-31) — Gross PPE: 49822.00
IR1.AX balance_sheet (annual, 2022-03-31) — Invested Capital: 4206528.00
IR1.AX cash_flow (annual, 2022-03-31) — Investing Cash Flow: -54248.00
IR1.AX cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 7000000.00
IR1.AX balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 49822.00
IR1.AX cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 6377295.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -3236744.00
IR1.AX balance_sheet (annual, 2022-03-31) — Net PPE: 49822.00
IR1.AX cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -54248.00
IR1.AX balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 4206528.00
IR1.AX income_statement (annual, 2022-03-31) — Normalized EBITDA: -3232318.00
IR1.AX income_statement (annual, 2022-03-31) — Normalized Income: -3236744.00
IR1.AX income_statement (annual, 2022-03-31) — Operating Income: -3236744.00
IR1.AX balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 87250000.00
IR1.AX cash_flow (annual, 2022-03-31) — Other Cash Paymentsfrom Operating Activities: -1383740.00
IR1.AX cash_flow (annual, 2022-03-31) — Other Cash Receiptsfrom Operating Activities: -110000.00
IR1.AX balance_sheet (annual, 2022-03-31) — Other Equity Adjustments: 680178.00
IR1.AX income_statement (annual, 2022-03-31) — Other Gand A: 172121.00
IR1.AX income_statement (annual, 2022-03-31) — Other Operating Expenses: 2065411.00
IR1.AX balance_sheet (annual, 2022-03-31) — Other Payable: 59510.00
IR1.AX balance_sheet (annual, 2022-03-31) — Other Receivables: 29896.00
IR1.AX balance_sheet (annual, 2022-03-31) — Payables: 155553.00
IR1.AX balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 155553.00
IR1.AX cash_flow (annual, 2022-03-31) — Paymentsto Suppliersfor Goodsand Services: -1135683.00
IR1.AX balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13661.00
IR1.AX balance_sheet (annual, 2022-03-31) — Prepaid Assets: 135982.00
IR1.AX income_statement (annual, 2022-03-31) — Pretax Income: -3236744.00
IR1.AX cash_flow (annual, 2022-03-31) — Purchase Of PPE: -54248.00
IR1.AX balance_sheet (annual, 2022-03-31) — Receivables: 29896.00
IR1.AX income_statement (annual, 2022-03-31) — Reconciled Depreciation: 4426.00
IR1.AX cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -622705.00
IR1.AX balance_sheet (annual, 2022-03-31) — Retained Earnings: -5036767.00
IR1.AX income_statement (annual, 2022-03-31) — Salaries And Wages: 968036.00
IR1.AX income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 26750.00
IR1.AX income_statement (annual, 2022-03-31) — Selling General And Administration: 1166907.00
IR1.AX balance_sheet (annual, 2022-03-31) — Share Issued: 87250000.00
IR1.AX balance_sheet (annual, 2022-03-31) — Stockholders Equity: 4206528.00
IR1.AX balance_sheet (annual, 2022-03-31) — Tangible Book Value: 4206528.00
IR1.AX income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
IR1.AX income_statement (annual, 2022-03-31) — Tax Provision: 0.00
IR1.AX income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Assets: 4405742.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Capitalization: 4206528.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 4206528.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 199214.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 49822.00
IR1.AX balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IR1.AX balance_sheet (annual, 2022-03-31) — Working Capital: 4156706.00
IR1.AX income_statement (annual, 2023-03-31) — +Operating Expense: 12127412.00
IR1.AX balance_sheet (annual, 2023-03-31) — Accounts Payable: 256342.00
IR1.AX income_statement (annual, 2023-03-31) — Basic Average Shares: 96392137.00
IR1.AX income_statement (annual, 2023-03-31) — Basic EPS: -0.13
IR1.AX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 4190042.00
IR1.AX cash_flow (annual, 2023-03-31) — Capital Expenditure: -5190681.00
IR1.AX cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -5160968.00
IR1.AX balance_sheet (annual, 2023-03-31) — Capital Stock: 15840203.00
IR1.AX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 675419.00
IR1.AX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 675419.00
IR1.AX balance_sheet (annual, 2023-03-31) — Cash Financial: 675419.00
IR1.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 3454361.00
IR1.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -5190681.00
IR1.AX cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: -1779767.00
IR1.AX cash_flow (annual, 2023-03-31) — Changes In Cash: -3516087.00
IR1.AX cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -1779767.00
IR1.AX balance_sheet (annual, 2023-03-31) — Common Stock: 15840203.00
IR1.AX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 11917361.00
IR1.AX cash_flow (annual, 2023-03-31) — Common Stock Issuance: 3510000.00
IR1.AX cash_flow (annual, 2023-03-31) — Common Stock Payments: -128169.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Assets: 790905.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Debt: 145060.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 145060.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 245537.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Deferred Revenue: 245537.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Liabilities: 898318.00
IR1.AX balance_sheet (annual, 2023-03-31) — Current Provisions: 30000.00
IR1.AX income_statement (annual, 2023-03-31) — Depreciation Amortization Depletion Income Statement: 10513.00
IR1.AX income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 10513.00
IR1.AX income_statement (annual, 2023-03-31) — Depreciation Income Statement: 10513.00
IR1.AX income_statement (annual, 2023-03-31) — Diluted Average Shares: 96392137.00
IR1.AX income_statement (annual, 2023-03-31) — Diluted EPS: -0.13
IR1.AX income_statement (annual, 2023-03-31) — EBIT: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — EBITDA: -12116899.00
IR1.AX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 1464.00
IR1.AX cash_flow (annual, 2023-03-31) — End Cash Position: 675419.00
IR1.AX cash_flow (annual, 2023-03-31) — Financing Cash Flow: 3454361.00
IR1.AX cash_flow (annual, 2023-03-31) — Free Cash Flow: -6970448.00
IR1.AX balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 10459211.00
IR1.AX income_statement (annual, 2023-03-31) — General And Administrative Expense: 11226272.00
IR1.AX balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 29713.00
IR1.AX balance_sheet (annual, 2023-03-31) — Gross PPE: 11877531.00
IR1.AX balance_sheet (annual, 2023-03-31) — Invested Capital: 12062421.00
IR1.AX cash_flow (annual, 2023-03-31) — Investing Cash Flow: -5190681.00
IR1.AX cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3510000.00
IR1.AX cash_flow (annual, 2023-03-31) — Issuance Of Debt: 72530.00
IR1.AX cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 72530.00
IR1.AX balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 84257.00
IR1.AX cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3381831.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -12127412.00
IR1.AX cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -29713.00
IR1.AX cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 72530.00
IR1.AX cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 72530.00
IR1.AX balance_sheet (annual, 2023-03-31) — Net PPE: 11877531.00
IR1.AX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 11887648.00
IR1.AX income_statement (annual, 2023-03-31) — Normalized EBITDA: -12116899.00
IR1.AX income_statement (annual, 2023-03-31) — Normalized Income: -12127412.00
IR1.AX income_statement (annual, 2023-03-31) — Operating Income: -12127412.00
IR1.AX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 100580000.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Current Assets: 92011.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 145060.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 10459211.00
IR1.AX income_statement (annual, 2023-03-31) — Other Gand A: 726377.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 29713.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 45000.00
IR1.AX income_statement (annual, 2023-03-31) — Other Operating Expenses: 861627.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Payable: 200833.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Properties: 11793274.00
IR1.AX balance_sheet (annual, 2023-03-31) — Other Receivables: 23475.00
IR1.AX balance_sheet (annual, 2023-03-31) — Payables: 457175.00
IR1.AX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 457175.00
IR1.AX cash_flow (annual, 2023-03-31) — Paymentsto Suppliersfor Goodsand Services: -1779767.00
IR1.AX balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 20546.00
IR1.AX income_statement (annual, 2023-03-31) — Pretax Income: -12127412.00
IR1.AX cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -29713.00
IR1.AX balance_sheet (annual, 2023-03-31) — Receivables: 23475.00
IR1.AX income_statement (annual, 2023-03-31) — Reconciled Depreciation: 10513.00
IR1.AX cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -128169.00
IR1.AX balance_sheet (annual, 2023-03-31) — Retained Earnings: -14382053.00
IR1.AX income_statement (annual, 2023-03-31) — Salaries And Wages: 10499895.00
IR1.AX income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 29000.00
IR1.AX income_statement (annual, 2023-03-31) — Selling General And Administration: 11255272.00
IR1.AX balance_sheet (annual, 2023-03-31) — Share Issued: 100580000.00
IR1.AX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 11917361.00
IR1.AX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 11887648.00
IR1.AX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
IR1.AX income_statement (annual, 2023-03-31) — Tax Provision: 0.00
IR1.AX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Assets: 12743149.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Capitalization: 11917361.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Debt: 145060.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 11917361.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 898318.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 11952244.00
IR1.AX balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IR1.AX balance_sheet (annual, 2023-03-31) — Working Capital: -107413.00
IR1.AX income_statement (annual, 2024-03-31) — +Operating Expense: 17437668.00
IR1.AX balance_sheet (annual, 2024-03-31) — Accounts Payable: 1294904.00
IR1.AX balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 1081089.00
IR1.AX income_statement (annual, 2024-03-31) — Basic Average Shares: 129875036.00
IR1.AX income_statement (annual, 2024-03-31) — Basic EPS: -0.13
IR1.AX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 675419.00
IR1.AX cash_flow (annual, 2024-03-31) — Capital Expenditure: -9028350.00
IR1.AX cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -8875440.00
IR1.AX balance_sheet (annual, 2024-03-31) — Capital Stock: 50169095.00
IR1.AX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 9794751.00
IR1.AX balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 9794751.00
IR1.AX balance_sheet (annual, 2024-03-31) — Cash Financial: 9794751.00
IR1.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 22382466.00
IR1.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -8912736.00
IR1.AX cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: -4356790.00
IR1.AX cash_flow (annual, 2024-03-31) — Changes In Cash: 9112940.00
IR1.AX cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -4040387.00
IR1.AX cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: -432326.00
IR1.AX balance_sheet (annual, 2024-03-31) — Common Stock: 50169095.00
IR1.AX balance_sheet (annual, 2024-03-31) — Common Stock Equity: 39930258.00
IR1.AX cash_flow (annual, 2024-03-31) — Common Stock Issuance: 23258500.00
IR1.AX cash_flow (annual, 2024-03-31) — Common Stock Payments: -799961.00
IR1.AX balance_sheet (annual, 2024-03-31) — Current Assets: 10976171.00
IR1.AX balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 83643.00
IR1.AX balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 83643.00
IR1.AX balance_sheet (annual, 2024-03-31) — Current Liabilities: 1496885.00
IR1.AX balance_sheet (annual, 2024-03-31) — Current Provisions: 30000.00
IR1.AX income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 52259.00
IR1.AX income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 52259.00
IR1.AX income_statement (annual, 2024-03-31) — Depreciation Income Statement: 52259.00
IR1.AX income_statement (annual, 2024-03-31) — Diluted Average Shares: 129875036.00
IR1.AX income_statement (annual, 2024-03-31) — Diluted EPS: -0.13
IR1.AX income_statement (annual, 2024-03-31) — EBIT: -17302452.00
IR1.AX income_statement (annual, 2024-03-31) — EBITDA: -17250193.00
IR1.AX cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 6392.00
IR1.AX balance_sheet (annual, 2024-03-31) — Employee Benefits: 961.00
IR1.AX cash_flow (annual, 2024-03-31) — End Cash Position: 9794751.00
IR1.AX cash_flow (annual, 2024-03-31) — Financing Cash Flow: 22382466.00
IR1.AX cash_flow (annual, 2024-03-31) — Free Cash Flow: -13385140.00
IR1.AX balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 21464961.00
IR1.AX income_statement (annual, 2024-03-31) — General And Administrative Expense: 13492355.00
IR1.AX balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 20916.00
IR1.AX balance_sheet (annual, 2024-03-31) — Gross PPE: 30277972.00
IR1.AX income_statement (annual, 2024-03-31) — Interest Expense: 19293.00
IR1.AX income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 19293.00
IR1.AX income_statement (annual, 2024-03-31) — Interest Income: 135216.00
IR1.AX income_statement (annual, 2024-03-31) — Interest Income Non Operating: 135216.00
IR1.AX cash_flow (annual, 2024-03-31) — Interest Paid Direct: -19293.00
IR1.AX cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 19293.00
IR1.AX cash_flow (annual, 2024-03-31) — Interest Received Direct: 135216.00
IR1.AX balance_sheet (annual, 2024-03-31) — Invested Capital: 39930258.00
IR1.AX cash_flow (annual, 2024-03-31) — Investing Cash Flow: -8912736.00
IR1.AX cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 23258500.00
IR1.AX cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -76073.00
IR1.AX balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 330005.00
IR1.AX cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 115614.00
IR1.AX cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 22458539.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Net Interest Income: 115923.00
IR1.AX cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -76073.00
IR1.AX cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -76073.00
IR1.AX income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 115923.00
IR1.AX balance_sheet (annual, 2024-03-31) — Net PPE: 30277972.00
IR1.AX cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -152910.00
IR1.AX balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 39909342.00
IR1.AX balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 961.00
IR1.AX income_statement (annual, 2024-03-31) — Normalized EBITDA: -17250193.00
IR1.AX income_statement (annual, 2024-03-31) — Normalized Income: -17321745.00
IR1.AX income_statement (annual, 2024-03-31) — Operating Income: -17437668.00
IR1.AX balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 139034982.00
IR1.AX cash_flow (annual, 2024-03-31) — Other Cash Receiptsfrom Operating Activities: -432326.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Current Assets: 63304.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 21464961.00
IR1.AX income_statement (annual, 2024-03-31) — Other Gand A: 1221421.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 20916.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 153045.00
IR1.AX income_statement (annual, 2024-03-31) — Other Operating Expenses: 3838785.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Payable: 46726.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Properties: 29947967.00
IR1.AX balance_sheet (annual, 2024-03-31) — Other Receivables: 37027.00
IR1.AX balance_sheet (annual, 2024-03-31) — Payables: 1341630.00
IR1.AX balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 1341630.00
IR1.AX cash_flow (annual, 2024-03-31) — Paymentsto Suppliersfor Goodsand Services: -4040387.00
IR1.AX balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 41612.00
IR1.AX income_statement (annual, 2024-03-31) — Pretax Income: -17321745.00
IR1.AX cash_flow (annual, 2024-03-31) — Purchase Of PPE: -152910.00
IR1.AX balance_sheet (annual, 2024-03-31) — Receivables: 37027.00
IR1.AX income_statement (annual, 2024-03-31) — Reconciled Depreciation: 52259.00
IR1.AX cash_flow (annual, 2024-03-31) — Repayment Of Debt: -76073.00
IR1.AX cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -799961.00
IR1.AX balance_sheet (annual, 2024-03-31) — Retained Earnings: -31703798.00
IR1.AX income_statement (annual, 2024-03-31) — Salaries And Wages: 12270934.00
IR1.AX cash_flow (annual, 2024-03-31) — Sale Of Business: 115614.00
IR1.AX income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 54269.00
IR1.AX income_statement (annual, 2024-03-31) — Selling General And Administration: 13546624.00
IR1.AX balance_sheet (annual, 2024-03-31) — Share Issued: 139034982.00
IR1.AX balance_sheet (annual, 2024-03-31) — Stockholders Equity: 39930258.00
IR1.AX balance_sheet (annual, 2024-03-31) — Tangible Book Value: 39909342.00
IR1.AX income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
IR1.AX income_statement (annual, 2024-03-31) — Tax Provision: 0.00
IR1.AX income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Assets: 41428104.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Capitalization: 39930258.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 39930258.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1497846.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 30451933.00
IR1.AX balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 961.00
IR1.AX balance_sheet (annual, 2024-03-31) — Working Capital: 9479286.00
IR1.AX income_statement (annual, 2025-03-31) — +Operating Expense: 5649423.00
IR1.AX balance_sheet (annual, 2025-03-31) — Accounts Payable: 274389.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 274389.00
IR1.AX balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 1217596.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 1217596.00
IR1.AX income_statement (annual, 2025-03-31) — Basic Average Shares: 151389318.00
IR1.AX income_statement (annual, 2025-03-31) — Basic EPS: -0.04
IR1.AX cash_flow (annual, 2025-03-31) — Beginning Cash Position: 9794751.00
IR1.AX cash_flow (annual, 2025-03-31) — Capital Expenditure: -9559527.00
IR1.AX cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -9305180.00
IR1.AX balance_sheet (annual, 2025-03-31) — Capital Stock: 61719352.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 61719352.00
IR1.AX balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4171628.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4171628.00
IR1.AX balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4171628.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4171628.00
IR1.AX balance_sheet (annual, 2025-03-31) — Cash Financial: 4171628.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 4171628.00
IR1.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 7146434.00
IR1.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -9559527.00
IR1.AX cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -3173838.00
IR1.AX cash_flow (annual, 2025-03-31) — Changes In Cash: -5586931.00
IR1.AX cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -3232461.00
IR1.AX balance_sheet (annual, 2025-03-31) — Common Stock: 61719352.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Common Stock: 61719352.00
IR1.AX balance_sheet (annual, 2025-03-31) — Common Stock Equity: 44092652.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 44092652.00
IR1.AX cash_flow (annual, 2025-03-31) — Common Stock Issuance: 7635000.00
IR1.AX cash_flow (annual, 2025-03-31) — Common Stock Payments: -488566.00
IR1.AX balance_sheet (annual, 2025-03-31) — Current Assets: 5508115.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Current Assets: 5508115.00
IR1.AX balance_sheet (annual, 2025-03-31) — Current Liabilities: 355385.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 355385.00
IR1.AX balance_sheet (annual, 2025-03-31) — Current Provisions: 30000.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Current Provisions: 30000.00
IR1.AX income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 88691.00
IR1.AX income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 88691.00
IR1.AX income_statement (annual, 2025-03-31) — Depreciation Income Statement: 88691.00
IR1.AX income_statement (annual, 2025-03-31) — Diluted Average Shares: 151389318.00
IR1.AX income_statement (annual, 2025-03-31) — Diluted EPS: -0.04
IR1.AX income_statement (annual, 2025-03-31) — EBIT: -5649423.00
IR1.AX income_statement (annual, 2025-03-31) — EBITDA: -5560732.00
IR1.AX cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -36192.00
IR1.AX cash_flow (annual, 2025-03-31) — End Cash Position: 4171628.00
IR1.AX cash_flow (annual, 2025-03-31) — Financing Cash Flow: 7146434.00
IR1.AX cash_flow (annual, 2025-03-31) — Free Cash Flow: -12733365.00
IR1.AX balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 17122774.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 17122774.00
IR1.AX income_statement (annual, 2025-03-31) — General And Administrative Expense: 3423320.00
IR1.AX balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 15492.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 15492.00
IR1.AX balance_sheet (annual, 2025-03-31) — Gross PPE: 38700060.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 38700060.00
IR1.AX income_statement (annual, 2025-03-31) — Interest Income: 62281.00
IR1.AX income_statement (annual, 2025-03-31) — Interest Income Non Operating: 62281.00
IR1.AX cash_flow (annual, 2025-03-31) — Interest Paid Direct: -3658.00
IR1.AX cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 3658.00
IR1.AX cash_flow (annual, 2025-03-31) — Interest Received Direct: 62281.00
IR1.AX balance_sheet (annual, 2025-03-31) — Invested Capital: 44092652.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 44092652.00
IR1.AX cash_flow (annual, 2025-03-31) — Investing Cash Flow: -9559527.00
IR1.AX cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 7635000.00
IR1.AX balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 448961.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 448961.00
IR1.AX cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 7146434.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Net Interest Income: 62281.00
IR1.AX income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 62281.00
IR1.AX balance_sheet (annual, 2025-03-31) — Net PPE: 38700060.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Net PPE: 38700060.00
IR1.AX cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -254347.00
IR1.AX balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 44077160.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 44077160.00
IR1.AX income_statement (annual, 2025-03-31) — Normalized EBITDA: -5560732.00
IR1.AX income_statement (annual, 2025-03-31) — Normalized Income: -5615622.00
IR1.AX income_statement (annual, 2025-03-31) — Operating Income: -5649423.00
IR1.AX balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 176559382.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 176559382.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Current Assets: 7776.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7776.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 17122774.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 17122774.00
IR1.AX income_statement (annual, 2025-03-31) — Other Gand A: 943436.00
IR1.AX income_statement (annual, 2025-03-31) — Other Income Expense: -28480.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 15492.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 15492.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 224370.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 224370.00
IR1.AX income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: -28480.00
IR1.AX income_statement (annual, 2025-03-31) — Other Operating Expenses: 2007004.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Properties: 38251099.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Properties: 38251099.00
IR1.AX balance_sheet (annual, 2025-03-31) — Other Receivables: 111115.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 111115.00
IR1.AX balance_sheet (annual, 2025-03-31) — Payables: 274389.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Payables: 274389.00
IR1.AX balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 274389.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 274389.00
IR1.AX cash_flow (annual, 2025-03-31) — Paymentsto Suppliersfor Goodsand Services: -3232461.00
IR1.AX balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 50996.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 50996.00
IR1.AX income_statement (annual, 2025-03-31) — Pretax Income: -5615622.00
IR1.AX cash_flow (annual, 2025-03-31) — Purchase Of PPE: -254347.00
IR1.AX balance_sheet (annual, 2025-03-31) — Receivables: 111115.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Receivables: 111115.00
IR1.AX income_statement (annual, 2025-03-31) — Reconciled Depreciation: 88691.00
IR1.AX cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -488566.00
IR1.AX balance_sheet (annual, 2025-03-31) — Retained Earnings: -34749474.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -34749474.00
IR1.AX income_statement (annual, 2025-03-31) — Salaries And Wages: 2479884.00
IR1.AX income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 130408.00
IR1.AX income_statement (annual, 2025-03-31) — Selling General And Administration: 3553728.00
IR1.AX balance_sheet (annual, 2025-03-31) — Share Issued: 176559382.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Share Issued: 176559382.00
IR1.AX balance_sheet (annual, 2025-03-31) — Stockholders Equity: 44092652.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 44092652.00
IR1.AX balance_sheet (annual, 2025-03-31) — Tangible Book Value: 44077160.00
IR1.AX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 44077160.00
IR1.AX income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IR1.AX income_statement (annual, 2025-03-31) — Tax Provision: 0.00